TransDigm Group Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
TransDigm Group Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 | 2017-09-30 | 2016-09-30 | 2015-09-30 | 2014-09-30 | 2013-09-30 | 2012-09-30 | 2011-09-30 | 2010-09-30 | 2009-09-30 | 2008-12-27 | 2008-09-30 | 2007-12-29 | 2007-09-30 | 2006-12-30 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
operating activities: | |||||||||||||||||||||
net income | 467,000,000 | 414,000,000 | 265,000,000 | 208,000,000 | 82,000,000 | 228,763,000 | 153,458,000 | 192,288,000 | 141,673,000 | 114,255,000 | 84,027,000 | 87,866,000 | 67,395,000 | 50,635,000 | 41,611,000 | 39,599,000 | 37,989,000 | 26,968,000 | 24,675,000 | 20,335,000 | |
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||||
depreciation | 41,000,000 | 36,000,000 | 31,000,000 | 28,000,000 | 31,000,000 | 27,937,000 | 15,149,000 | 13,013,000 | 12,396,000 | 10,020,000 | 8,585,000 | 7,368,000 | 6,305,000 | 5,417,000 | 4,054,000 | 3,405,000 | 3,489,000 | 3,444,000 | 3,182,000 | 3,225,000 | 2,551,000 |
amortization of intangible assets and product certification costs | 52,000,000 | 33,000,000 | 34,000,000 | 37,000,000 | 18,161,000 | 24,173,000 | |||||||||||||||
amortization of debt issuance costs, original issue discount and premium | 9,000,000 | 11,000,000 | 8,000,000 | 8,000,000 | 8,000,000 | 7,836,000 | 5,949,000 | 5,576,000 | |||||||||||||
amortization of inventory step-up | 13,000,000 | 0 | 2,000,000 | 0 | -32,421,000 | ||||||||||||||||
amortization of loss contract reserves | -11,000,000 | -7,000,000 | -11,000,000 | -8,000,000 | -4,000,000 | ||||||||||||||||
refinancing costs | -1,000,000 | 15,000,000 | 1,000,000 | 1,000,000 | -527,000 | 486,000 | 3,871,000 | -14,228,000 | 234,000 | 132,000 | 0 | 37,000 | |||||||||
gain on sale of businesses | 0 | -1,000,000 | 0 | ||||||||||||||||||
non-cash stock and deferred compensation expense | 59,000,000 | 26,000,000 | |||||||||||||||||||
deferred income taxes | 4,000,000 | -21,000,000 | 20,000,000 | 41,000,000 | -5,499,000 | 15,143,000 | -1,188,000 | 1,319,000 | -3,224,000 | -6,889,000 | -9,390,000 | 22,880,000 | 1,528,000 | 1,800,000 | 3,641,000 | 2,006,000 | 2,347,000 | 1,088,000 | |||
foreign currency exchange losses | 17,000,000 | -7,000,000 | |||||||||||||||||||
changes in assets/liabilities, net of effects from acquisitions and sales of businesses: | |||||||||||||||||||||
trade accounts receivable | -62,000,000 | -78,000,000 | -99,000,000 | -101,000,000 | 5,000,000 | -16,922,000 | -42,950,000 | -33,474,000 | -42,766,000 | -18,374,000 | 624,000 | -2,315,000 | 4,971,000 | -14,907,000 | -8,895,000 | 4,019,000 | -2,964,000 | 4,751,000 | 7,815,000 | ||
inventories | 36,000,000 | -17,000,000 | -26,000,000 | 39,000,000 | 64,000,000 | 64,330,000 | 11,184,000 | 5,452,000 | 13,616,000 | 2,023,000 | 18,000 | 1,473,000 | 3,282,000 | -2,283,000 | -2,461,000 | 4,816,000 | -6,173,000 | 2,562,000 | -1,366,000 | 2,440,000 | -2,333,000 |
income taxes receivable | 27,000,000 | ||||||||||||||||||||
other assets | -33,000,000 | -28,000,000 | -33,000,000 | 2,000,000 | -22,000,000 | -2,292,000 | -2,313,000 | -6,460,000 | -6,697,000 | -12,545,000 | -7,568,000 | -706,000 | -13,478,000 | -662,000 | -435,000 | -2,665,000 | -787,000 | 1,243,000 | 1,310,000 | 118,000 | 6,610,000 |
accounts payable | -2,000,000 | 16,000,000 | 35,000,000 | 22,000,000 | -14,000,000 | 5,804,000 | 17,351,000 | 1,988,000 | 20,446,000 | 14,128,000 | 21,400,000 | 32,157,000 | -2,064,000 | 7,696,000 | 12,821,000 | 15,069,000 | 269,000 | -996,000 | -2,072,000 | 168,000 | 344,000 |
accrued interest | -58,000,000 | -74,000,000 | -3,000,000 | 17,000,000 | -24,000,000 | -98,960,000 | 7,698,000 | -1,699,000 | -16,985,000 | ||||||||||||
accrued and other liabilities | -23,000,000 | 20,000,000 | 33,000,000 | -23,000,000 | 55,000,000 | -41,650,000 | 2,610,000 | -653,000 | -7,478,000 | -59,340,000 | -519,000 | 56,606,000 | 36,427,000 | 31,025,000 | -21,454,000 | -9,741,000 | 10,391,000 | -13,348,000 | 8,500,000 | -15,831,000 | 6,547,000 |
net cash from operating activities | 572,000,000 | 462,000,000 | 273,000,000 | 289,000,000 | 222,000,000 | 247,116,000 | 331,263,000 | 233,517,000 | 224,494,000 | 147,511,000 | 191,693,000 | 203,170,000 | 156,062,000 | 116,867,000 | 42,041,000 | 68,095,000 | 66,220,000 | 39,715,000 | 60,228,000 | 22,317,000 | 38,453,000 |
investing activities: | |||||||||||||||||||||
capital expenditures | -41,000,000 | -37,000,000 | -33,000,000 | -25,000,000 | -43,000,000 | -8,696,000 | -11,902,000 | -9,037,000 | -5,805,000 | -3,016,000 | -3,996,000 | -1,733,000 | -3,633,000 | -2,401,000 | -3,113,000 | -2,496,000 | |||||
free cash flows | 531,000,000 | 425,000,000 | 240,000,000 | 264,000,000 | 179,000,000 | 182,997,000 | 191,268,000 | 147,025,000 | 111,062,000 | 39,025,000 | 64,099,000 | 64,487,000 | 36,082,000 | 57,827,000 | 19,204,000 | 35,957,000 | |||||
acquisition of businesses, net of cash acquired | -661,000,000 | -12,000,000 | -15,000,000 | -12,000,000 | -256,058,000 | -330,780,000 | 0 | -1,415,000 | -34,725,000 | -288,364,000 | |||||||||||
other investing transactions | 0 | ||||||||||||||||||||
net cash from investing activities | -702,000,000 | -48,000,000 | -48,000,000 | -37,000,000 | -43,000,000 | 148,385,000 | -108,904,000 | -16,130,000 | -270,033,000 | -345,352,000 | -8,696,000 | -7,601,000 | -26,112,000 | -294,169,000 | -70,774,000 | -92,666,000 | -68,152,000 | -73,071,000 | -2,401,000 | -38,611,000 | -47,746,000 |
financing activities: | |||||||||||||||||||||
proceeds from exercise of stock options | 32,000,000 | 36,000,000 | 33,000,000 | 22,000,000 | 27,000,000 | 17,596,000 | 16,962,000 | 3,131,000 | 4,792,000 | 8,692,000 | 12,089,000 | 6,688,000 | 2,772,000 | 1,463,000 | 3,068,000 | 5,123,000 | 560,000 | 1,500,000 | 1,525,000 | 717,000 | 1,304,000 |
dividends and dividend equivalent payments | 0 | 0 | |||||||||||||||||||
repurchases of common stock | 0 | ||||||||||||||||||||
proceeds from issuance of senior subordinated notes | |||||||||||||||||||||
repayments of senior subordinated notes | 0 | ||||||||||||||||||||
proceeds from issuance of senior secured notes | 1,486,000,000 | 1,436,000,000 | |||||||||||||||||||
repayments of senior secured notes | 0 | 0 | |||||||||||||||||||
proceeds from term loans | 1,483,000,000 | 0 | -78,000 | ||||||||||||||||||
proceeds from trade receivable securitization facility | 37,000,000 | ||||||||||||||||||||
repayment on term loans | -18,000,000 | -16,000,000 | -19,000,000 | -19,000,000 | -1,236,245,000 | -8,918,000 | |||||||||||||||
financing costs and other | -1,000,000 | -2,000,000 | -1,000,000 | ||||||||||||||||||
net cash from financing activities | 3,019,000,000 | -5,000,000 | -1,032,000,000 | 4,000,000 | -15,000,000 | -1,640,287,000 | -3,954,000 | -541,068,000 | -34,200,000 | -3,302,000 | -91,758,000 | 99,795,000 | 7,671,000 | 4,234,000 | 4,456,000 | 11,090,000 | -7,821,000 | 3,225,000 | 6,542,000 | 2,045,000 | 2,632,000 |
effect of exchange rate changes on cash and cash equivalents | 12,000,000 | -8,000,000 | 0 | 2,000,000 | 4,000,000 | -4,540,000 | 1,239,000 | 3,686,000 | 38,000 | -174,000 | -825,000 | 204,000 | 185,000 | ||||||||
net decrease in cash and cash equivalents | -6,661,000 | ||||||||||||||||||||
cash and cash equivalents, beginning of period | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 159,062,000 | 105,946,000 | 61,217,000 | ||||
cash and cash equivalents, end of period | 2,901,000,000 | 401,000,000 | -807,000,000 | 258,000,000 | 168,000,000 | -1,249,326,000 | 219,644,000 | -319,995,000 | -79,701,000 | -201,317,000 | 90,414,000 | 295,568,000 | 137,806,000 | -173,068,000 | 149,309,000 | 170,315,000 | 54,556,000 | ||||
supplemental disclosure of cash flow information: | |||||||||||||||||||||
cash paid during the period for interest | 381,000,000 | 352,000,000 | 266,000,000 | 234,000,000 | 285,000,000 | 344,344,000 | 165,313,000 | 153,423,000 | 153,234,000 | 169,312,000 | 87,888,000 | 30,096,000 | 20,979,000 | 16,169,000 | 45,928,000 | 29,346,000 | 11,193,000 | 33,655,000 | 14,390,000 | 37,421,000 | 12,713,000 |
cash paid during the period for income taxes, net of refunds | 67,000,000 | 29,000,000 | 82,000,000 | 32,000,000 | 29,000,000 | ||||||||||||||||
foreign currency exchange (gains) losses | |||||||||||||||||||||
net increase in cash and cash equivalents | 2,901,000,000 | 401,000,000 | 258,000,000 | 168,000,000 | -1,249,326,000 | 219,644,000 | -319,995,000 | -79,701,000 | -201,317,000 | 90,414,000 | 295,568,000 | 137,806,000 | -173,068,000 | -24,277,000 | -13,481,000 | -9,753,000 | -30,131,000 | 64,369,000 | -14,249,000 | ||
income taxes payable | 98,000,000 | 37,000,000 | |||||||||||||||||||
income from discontinued operations, net of tax | 0 | ||||||||||||||||||||
cash refund (contribution) for the erp settlement | 1,000,000 | ||||||||||||||||||||
income taxes (receivable) payable | 58,000,000 | ||||||||||||||||||||
repayment on revolving credit facility | 0 | 0 | |||||||||||||||||||
gain on settlement of the esterline retirement plan | |||||||||||||||||||||
cash refund for the erp settlement | |||||||||||||||||||||
effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||||||||||||||||||
net increase in cash, cash equivalents and restricted cash | |||||||||||||||||||||
cash, cash equivalents and restricted cash, beginning of period | |||||||||||||||||||||
cash, cash equivalents and restricted cash, end of period | |||||||||||||||||||||
cash paid (refunded) during the period for income taxes, net of refunds | |||||||||||||||||||||
gain on insurance proceeds from fire | -3,000,000 | ||||||||||||||||||||
net proceeds from sale of businesses | 0 | 0 | |||||||||||||||||||
insurance proceeds for fixed assets damaged from fire | 0 | ||||||||||||||||||||
proceeds from revolving credit facility | 0 | 0 | |||||||||||||||||||
dividend equivalent payments | |||||||||||||||||||||
non-cash stock compensation expense | 38,000,000 | 24,000,000 | |||||||||||||||||||
cash (refunded) paid during the period for income taxes | |||||||||||||||||||||
loss on settlement of the esterline retirement plan | 1,000,000 | ||||||||||||||||||||
contribution to the unfunded portion of the erp | 0 | ||||||||||||||||||||
foreign currency exchange (gain) loss | |||||||||||||||||||||
cash paid (refunded) during the period for income taxes | |||||||||||||||||||||
foreign currency exchange gain | |||||||||||||||||||||
treasury stock purchases | |||||||||||||||||||||
proceeds from issuances of senior secured and subordinated notes | |||||||||||||||||||||
foreign currency exchange loss | |||||||||||||||||||||
redemption of 6.50% senior subordinated notes due 2024 | |||||||||||||||||||||
redemption of 6.50% senior subordinated notes due 2025 | |||||||||||||||||||||
redemption of 6.00% senior subordinated notes due 2022 | |||||||||||||||||||||
proceeds from 5.50% senior subordinated notes due 2027 | 0 | ||||||||||||||||||||
proceeds from 8.00% senior secured notes due 2025 | -2,000,000 | ||||||||||||||||||||
proceeds from 6.25% senior secured notes due 2026 | -2,000,000 | ||||||||||||||||||||
proceeds from 4.625% senior subordinated notes due 2029 | |||||||||||||||||||||
proceeds from 4.875% senior subordinated notes due 2029 | |||||||||||||||||||||
income taxes payable/ | |||||||||||||||||||||
net income from discontinued operations | 1,531,000 | -3,082,000 | |||||||||||||||||||
amortization of intangible assets | 41,000,000 | 50,219,000 | 15,876,000 | 13,259,000 | 16,312,000 | 11,276,000 | 12,184,000 | ||||||||||||||
non-cash stock compensation | |||||||||||||||||||||
changes in assets/liabilities, net of effects from acquisitions of businesses: | |||||||||||||||||||||
income taxes receivable/payable | 6,733,000 | 29,431,000 | 31,001,000 | -8,317,000 | 56,552,000 | 48,104,000 | 34,074,000 | -2,538,000 | 10,966,000 | 16,259,000 | 14,362,000 | ||||||||||
net (income) income from discontinued operations | |||||||||||||||||||||
income taxes (receivable) or payable | |||||||||||||||||||||
payments made in connection with acquisitions | -85,357,000 | ||||||||||||||||||||
proceeds in connection with the sale of discontinued operations | 0 | ||||||||||||||||||||
redemption of senior subordinated notes due 2020 | |||||||||||||||||||||
redemption of senior subordinated notes due 2022 | 1,000,000 | ||||||||||||||||||||
proceeds from 7.50% senior subordinated notes due 2027 | |||||||||||||||||||||
non-cash equity compensation | 22,070,000 | 12,817,000 | 14,487,000 | 8,065,000 | 7,483,000 | 2,904,000 | 7,758,000 | 5,721,000 | 1,667,000 | 1,599,000 | 808,000 | 947,000 | 1,217,000 | 1,034,000 | |||||||
payments made in connection with acquisitions, net of cash acquired | |||||||||||||||||||||
treasury stock purchased | 0 | 0 | -87,450,000 | 0 | 0 | ||||||||||||||||
repayments on term loans | -19,107,000 | ||||||||||||||||||||
cash tender and redemption of senior subordinated notes due 2020 | 0 | ||||||||||||||||||||
financing fees and other | 73,000 | ||||||||||||||||||||
proceeds from senior subordinated notes | |||||||||||||||||||||
proceeds from senior secured notes due 2026 | -148,000 | ||||||||||||||||||||
other | -1,271,000 | ||||||||||||||||||||
net income including noncontrolling interests | |||||||||||||||||||||
Capital Expenditures | -14,572,000 | ||||||||||||||||||||
special dividends and dividend equivalent payments | |||||||||||||||||||||
cash tender and redemption of senior subordinated notes due 2021, including premium | 0 | ||||||||||||||||||||
cash paid during the period for income taxes | 31,674,000 | 5,649,000 | 27,396,000 | 38,217,000 | -3,372,000 | 11,073,000 | 15,262,000 | 25,780,000 | 19,054,000 | ||||||||||||
net income from continuing operations including noncontrolling interests | |||||||||||||||||||||
proceeds from senior subordinated notes due 2027 | |||||||||||||||||||||
proceeds from senior subordinated notes due 2026 | |||||||||||||||||||||
proceeds (payments made) in connection with the sale (purchase) of discontinued operations | -303,000 | ||||||||||||||||||||
dividends paid | 0 | 0 | -6,098,000 | -1,288,944,000 | 0 | 0 | 0 | ||||||||||||||
special dividend and dividend equivalent payments | |||||||||||||||||||||
proceeds from additional senior subordinated notes due 2025 | |||||||||||||||||||||
cash refunded during the period for income taxes | |||||||||||||||||||||
excess tax benefits related to share-based payment arrangements | -11,385,000 | -11,228,000 | -22,416,000 | -10,024,000 | -6,779,000 | -1,388,000 | |||||||||||||||
acquisition of schroth, net of cash acquired | |||||||||||||||||||||
payments made in connection with acquisitions - see note 3 | |||||||||||||||||||||
proceeds from 2017 term loans | |||||||||||||||||||||
proceeds from 2016 term loans | 13,639,000 | ||||||||||||||||||||
cash tender and redemption of the 2021 notes, including premium | |||||||||||||||||||||
proceeds from additional 2025 notes offering | |||||||||||||||||||||
amortization of debt issuance costs and original issue discount | 4,500,000 | ||||||||||||||||||||
net gain on sale of real estate | 0 | ||||||||||||||||||||
cash proceeds from sale of real estate | 0 | ||||||||||||||||||||
proceeds from revolving commitment | |||||||||||||||||||||
repayment on 2016 term loans | |||||||||||||||||||||
repayment on revolving commitment | |||||||||||||||||||||
proceeds from 2026 notes | |||||||||||||||||||||
repurchase of 2018 notes | |||||||||||||||||||||
proceeds from 2015 term loans | |||||||||||||||||||||
proceeds from revolving commitments | |||||||||||||||||||||
repayment on revolving commitments | |||||||||||||||||||||
proceeds from senior subordinated notes due 2025 | |||||||||||||||||||||
amortization of debt issuance costs | |||||||||||||||||||||
amortization of debt issue costs | 3,808,000 | 4,037,000 | 3,076,000 | 3,401,000 | 2,611,000 | 930,000 | 461,000 | ||||||||||||||
cash proceeds from sale of investment | 5,850,000 | ||||||||||||||||||||
repayment on 2015 term loans | |||||||||||||||||||||
proceeds from 2025 notes | |||||||||||||||||||||
treasury stock repurchased | |||||||||||||||||||||
proceeds from 2015 term loan - net | |||||||||||||||||||||
proceeds from 2014 term loan - net | |||||||||||||||||||||
repayment on 2014 term loan | |||||||||||||||||||||
repayment on 2013 term loan | |||||||||||||||||||||
proceeds from senior subordinated notes due 2025 - net | |||||||||||||||||||||
proceeds from senior subordinated notes due 2022 and 2024 - net | |||||||||||||||||||||
repurchase of senior subordinated notes due 2018 | -17,000 | ||||||||||||||||||||
proceeds from trade receivable securitization facility - net | |||||||||||||||||||||
other financing activities | |||||||||||||||||||||
repayment on 2014 term loan credit facility | |||||||||||||||||||||
proceeds from 2014 revolving credit facility | |||||||||||||||||||||
cash proceeds from sale of business | |||||||||||||||||||||
proceeds from credit facility—net | |||||||||||||||||||||
repayment on credit facility | |||||||||||||||||||||
proceeds from senior subordinated notes—net | |||||||||||||||||||||
proceeds from trade receivable securitization facility—net | |||||||||||||||||||||
proceeds from 2014 credit facility - net | |||||||||||||||||||||
proceeds from 2013 credit facility - net | |||||||||||||||||||||
repayment on 2013 credit facility | -7,760,000 | ||||||||||||||||||||
proceeds from 2011 credit facility - net | |||||||||||||||||||||
repayment on 2011 credit facility | 0 | ||||||||||||||||||||
proceeds from senior subordinated notes due 2020 - net | |||||||||||||||||||||
cash proceeds from sales of discontinued operations | 0 | ||||||||||||||||||||
proceeds from 2013 credit facility—net | |||||||||||||||||||||
proceeds from 2011 credit facility—net | |||||||||||||||||||||
proceeds from senior subordinated notes due 2021—net | |||||||||||||||||||||
proceeds from senior subordinated notes due 2020—net | |||||||||||||||||||||
proceeds from senior subordinated notes due 2018—net | |||||||||||||||||||||
repurchase of senior subordinated notes due 2014 | 0 | ||||||||||||||||||||
repayment on 2006 credit facility | |||||||||||||||||||||
cash proceeds from working capital settlement | |||||||||||||||||||||
proceeds from senior secured credit facility - net | |||||||||||||||||||||
repayment on senior secured credit facility | |||||||||||||||||||||
proceeds from new senior secured credit facility—net | |||||||||||||||||||||
repayment on new senior secured credit facility | -5,125,000 | -3,875,000 | |||||||||||||||||||
proceeds from senior subordinated notes due 2014—net | |||||||||||||||||||||
repayment of existing senior secured credit facility | 0 | ||||||||||||||||||||
cash proceeds from sale of discontinued operations | |||||||||||||||||||||
proceeds from new senior secured credit facility - net | |||||||||||||||||||||
proceeds from senior subordinated notes due 2018 - net | |||||||||||||||||||||
proceeds from senior subordinated notes due 2014 - net | |||||||||||||||||||||
gain on sale of discontinued operations | |||||||||||||||||||||
proceeds from new senior secured credit facility | |||||||||||||||||||||
proceeds from senior subordinated notes due 2018-net of discount and financing fees | |||||||||||||||||||||
amortization of intangibles | 3,577,000 | 3,774,000 | 3,224,000 | 3,161,000 | 3,311,000 | 3,687,000 | 1,642,000 | ||||||||||||||
changes in assets and liabilities, net of effects from acquisitions of businesses: | |||||||||||||||||||||
proceeds from sale of real estate | |||||||||||||||||||||
proceeds from senior subordinated notes-net of discount and financing fees | 0 | ||||||||||||||||||||
cash and cash equivalents—beginning of period | |||||||||||||||||||||
cash and cash equivalents—end of period | |||||||||||||||||||||
net cash paid during the period for income taxes | |||||||||||||||||||||
amortization of debt issue costs, note premium and discount | |||||||||||||||||||||
acquisition of businesses | -88,670,000 | -66,419,000 | |||||||||||||||||||
amortization/write-off of debt issue costs | 923,000 | ||||||||||||||||||||
excess tax benefit from exercise of stock options | -5,967,000 | -714,000 | -1,725,000 | -5,017,000 | |||||||||||||||||
borrowings under senior secured credit facility—net of fees | |||||||||||||||||||||
proceeds from 7 3/4% senior subordinated notes—net of fees | |||||||||||||||||||||
amortization of debt issue costs and note premium | 813,000 | ||||||||||||||||||||
changes in assets/liabilities, net of effects from acquisition of businesses: | |||||||||||||||||||||
purchase of treasury stock | -9,095,000 | ||||||||||||||||||||
cash paid (received) during the period for income taxes | 2,920,000 | ||||||||||||||||||||
loss on repayment of senior subordinated notes | |||||||||||||||||||||
deferred compensation liability | 688,000 | 465,000 | |||||||||||||||||||
interest on senior unsecured promissory notes | |||||||||||||||||||||
acquisitions of businesses | -69,438,000 | ||||||||||||||||||||
borrowings under td group loan facility—net of fees | |||||||||||||||||||||
repayment of amounts borrowed under former credit facility | |||||||||||||||||||||
repayment of 8 3/8% senior subordinated notes | |||||||||||||||||||||
repayment of td group loan facility | |||||||||||||||||||||
repayment of senior unsecured promissory notes | |||||||||||||||||||||
proceeds from issuance of senior subordinated notes, net of fees | |||||||||||||||||||||
borrowings under senior secured credit facility, net of fees | |||||||||||||||||||||
changes in assets/liabilities, net of effects from acquisition of business: | |||||||||||||||||||||
acquisition of business | -45,250,000 | ||||||||||||||||||||
cash received during the period for income taxes | 780,000 | ||||||||||||||||||||
purchase of marketable securities | |||||||||||||||||||||
sales and maturity of marketable securities | |||||||||||||||||||||
payment of license obligation | |||||||||||||||||||||
premium paid to redeem 8 3/8% senior subordinated notes | |||||||||||||||||||||
accounts receivable | 1,025,000 | ||||||||||||||||||||
interest on unsecured promissory notes | |||||||||||||||||||||
proceeds from issuance of 7 3/4% senior subordinated notes, net of fees | |||||||||||||||||||||
repayment of amounts borrowed under the former credit facility | |||||||||||||||||||||
repayment of unsecured promissory notes | |||||||||||||||||||||
borrowings under td group loan facility, net of fees | |||||||||||||||||||||
tax benefit from exercise of stock options | 1,328,000 | ||||||||||||||||||||
non-cash stock option costs and restricted stock amortization | 806,000 | ||||||||||||||||||||
changes in assets/liabilities, net of effects from acqusition of businesses: | |||||||||||||||||||||
cash (received) / paid during the period for income taxes | -72,000 | ||||||||||||||||||||
inventory purchase accounting charge | |||||||||||||||||||||
non-cash stock option costs | |||||||||||||||||||||
income taxes receivable and other assets | |||||||||||||||||||||
borrowings under new senior secured credit facility—net of fees | |||||||||||||||||||||
purchase of common stock | |||||||||||||||||||||
net cash paid/(received) during the period for income taxes |
We provide you with 20 years of cash flow statements for TransDigm Group stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of TransDigm Group stock. Explore the full financial landscape of TransDigm Group stock with our expertly curated income statements.
The information provided in this report about TransDigm Group stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.